The drug, l-cyclohexyl-2-methylaminopropane, is used commercially in a volatile form in an inhaler ("Benzedrex" inhaler) for its vasoconstrictive and detumescent effect on the nasal mucous membrane.
Discover how Corcept Therapeutics Inc's patented method using miricorilant can effectively treat antipsychotic-induced weight gain and metabolic issues.
*In instances where patient numbers were not reported they were calculated from the percentages, and in instances where percentages were not reported, percentages were calculated from patient numbers.